Boulding Mark Elliott Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
38
Insider Sells Sum
$27.41M

Insider Activity of Boulding Mark Elliott

According to the SEC Form 4 filings, Boulding Mark Elliott, being in a position of

  1. EXEC. VP AND CLO at PTC Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 59324 shares for $4.51M,
    over all time since 2014-03-20, has bought 0 shares, and sold 647624 shares for $35.7M.

Biography of Boulding Mark Elliott

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $4,511,97419100

Comparison of Insiders on Amount of Buys and Sells

2026-10-09SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
192
0.0002%
$64.26$12,338-4.9%
2026-10-06SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
435
0.0005%
$64.16$27,910-2.16%
2026-10-05SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
1,638
0.002%
$64.03$104,881-1.71%
2026-08-17SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
2,813
0.0034%
$72.57$204,127-10.87%
2026-07-06SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
4,478
0.0054%
$84.90$380,203-19.46%
2026-07-06SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
3,733
0.0045%
$84.61$315,850-19.46%
2026-06-17SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
10,462
0.0126%
$78.65$822,868-10.92%
2026-05-15SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
2,812
0.0034%
$72.18$202,958-1.15%
2026-05-08SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
3,540
0.0046%
$78.97$279,570-3.83%
2026-04-06SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
2,265
0.0028%
$69.45$157,293+2.53%
2026-02-19SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
3,019
0.0038%
$69.48$209,763-0.92%
2026-02-18SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
3,081
0.0039%
$69.36$213,698+0.54%
2026-02-17SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
2,813
0.0035%
$69.29$194,914+0.13%
2026-01-09SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
2,314
0.0029%
$77.93$180,320-9.17%
2026-01-08SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
4,033
0.005%
$76.56$308,760-8.31%
2026-01-07SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
4,879
0.0061%
$77.44$377,825-8.73%
2026-01-06SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
1,739
0.0022%
$76.95$133,816-8.07%
2026-01-05SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
2,266
0.0028%
$75.55$171,192-8.13%
2025-11-17SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
2,812
0.0035%
$75.99$213,687-5.74%
2025-10-07SalePTC Therapeutics, Inc.
PTCT
EXEC. VP AND CLO
3,375
0.0042%
$63.43$214,091+12.19%
Total: 65
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.